Video-based teach-to-goal intervention on inhaler technique on adults with asthma and COPD: A randomized controlled trial.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
02
01
2023
accepted:
17
05
2023
medline:
12
6
2023
pubmed:
9
6
2023
entrez:
9
6
2023
Statut:
epublish
Résumé
Incorrect use of inhalers is a problem associated with poor patient outcomes. Despite improvement in the technique after verbal educations, this deteriorates over-time requiring re-enforcement through different educative strategies. This study aimed to assess the impact of a novel video-based teach-to-goal (TTG) educational intervention on: mastery of inhaler technique, disease control, medication adherence and disease-related quality of life (QoL) over-time among asthma and COPD patients. This prospective, open-label, randomized controlled trial was registered in ClinicalTrials.gov: Identifier NCT05664347. After baseline assessment participants received either a verbal (control group) or a video-based (intervention group) TTG strategy. After 3-month the intervention was assessed for impact on the intended outcomes. Inhaler technique was assessed using standardized checklists, disease control using the Asthma control test and COPD assessment test respectively for asthma and COPD patients while adherence using the Morisky Green Levine scale. For QoL, the mini asthma quality of life questionnaire and the St. George respiratory questionnaire were used for asthmatic and COPD patients, respectively. Differences in outcomes between intervention-control groups were analyzed using either Chi-Square (X2)/Fisher Exact or Mann Whitney test. The impact of intervention on outcomes over-time was examined using either McNemar or Wilcoxon test. At baseline, intervention (n = 51) and control (n = 52) groups had comparable demographic/clinical characteristics. At follow-up, inhaler technique improved among intervention group compared to control group (93.4% vs 67%) and to baseline (93.4% to 49.5%), (P<0.05). Similarly, medication adherence ameliorated among the intervention group in comparison to control group (88.2% to 61.5%) and to baseline (88.2% to 66.7%), (P<0.05). In regards to disease control, results showed an amelioration among the intervention group compared to baseline (35.3% to 54.9%) (P<0.05). QoL scores improved significantly among asthma patients (intervention group) at follow-up vs baseline. Better scores were also observed for COPD patients compared to controls, (P<0.05). Video-based (TTG) was effective in enhancing inhaler technique over time as well as improving disease control, medication adherence, and QoL. ClinicalTrials.gov: NCT05664347. https://clinicaltrials.gov/ct2/show/NCT05664347.
Sections du résumé
BACKGROUND
Incorrect use of inhalers is a problem associated with poor patient outcomes. Despite improvement in the technique after verbal educations, this deteriorates over-time requiring re-enforcement through different educative strategies. This study aimed to assess the impact of a novel video-based teach-to-goal (TTG) educational intervention on: mastery of inhaler technique, disease control, medication adherence and disease-related quality of life (QoL) over-time among asthma and COPD patients.
METHODS
This prospective, open-label, randomized controlled trial was registered in ClinicalTrials.gov: Identifier NCT05664347. After baseline assessment participants received either a verbal (control group) or a video-based (intervention group) TTG strategy. After 3-month the intervention was assessed for impact on the intended outcomes. Inhaler technique was assessed using standardized checklists, disease control using the Asthma control test and COPD assessment test respectively for asthma and COPD patients while adherence using the Morisky Green Levine scale. For QoL, the mini asthma quality of life questionnaire and the St. George respiratory questionnaire were used for asthmatic and COPD patients, respectively. Differences in outcomes between intervention-control groups were analyzed using either Chi-Square (X2)/Fisher Exact or Mann Whitney test. The impact of intervention on outcomes over-time was examined using either McNemar or Wilcoxon test.
RESULTS
At baseline, intervention (n = 51) and control (n = 52) groups had comparable demographic/clinical characteristics. At follow-up, inhaler technique improved among intervention group compared to control group (93.4% vs 67%) and to baseline (93.4% to 49.5%), (P<0.05). Similarly, medication adherence ameliorated among the intervention group in comparison to control group (88.2% to 61.5%) and to baseline (88.2% to 66.7%), (P<0.05). In regards to disease control, results showed an amelioration among the intervention group compared to baseline (35.3% to 54.9%) (P<0.05). QoL scores improved significantly among asthma patients (intervention group) at follow-up vs baseline. Better scores were also observed for COPD patients compared to controls, (P<0.05).
CONCLUSION
Video-based (TTG) was effective in enhancing inhaler technique over time as well as improving disease control, medication adherence, and QoL.
TRIAL REGISTRATION
ClinicalTrials.gov: NCT05664347. https://clinicaltrials.gov/ct2/show/NCT05664347.
Identifiants
pubmed: 37294823
doi: 10.1371/journal.pone.0286870
pii: PONE-D-23-00031
pmc: PMC10256228
doi:
Banques de données
ClinicalTrials.gov
['NCT05664347']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0286870Informations de copyright
Copyright: © 2023 Al-Kharouf et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Respir Med. 2011 Dec;105(12):1815-22
pubmed: 21802271
Patient Educ Couns. 1997 Dec;32(1 Suppl):S87-95
pubmed: 9516764
Int J Tuberc Lung Dis. 2016 May;20(5):689-95
pubmed: 27084826
Diabet Med. 2012 Sep;29(9):e338-44
pubmed: 22672497
Chron Respir Dis. 2005;2(4):183-91
pubmed: 16541601
J Aerosol Med Pulm Drug Deliv. 2017 Feb;30(1):42-52
pubmed: 27676193
Int J Chron Obstruct Pulmon Dis. 2011;6:97-104
pubmed: 21407822
J Health Commun. 2011;16 Suppl 3:73-88
pubmed: 21951244
Value Health. 2016 Dec;19(8):996-1001
pubmed: 27987650
J Asthma. 2016;53(4):349-55
pubmed: 26666170
Chron Respir Dis. 2016 Feb;13(1):13-22
pubmed: 26396159
Int J Chron Obstruct Pulmon Dis. 2019 May 30;14:1209-1217
pubmed: 31213798
Clin Pharmacol. 2019 Jul 23;11:103-116
pubmed: 31413644
Rev Mal Respir. 1991;8(6):559-65
pubmed: 1685595
Prim Care Respir J. 2013 Dec;22(4):406-11
pubmed: 24042172
PLoS One. 2017 Mar 23;12(3):e0171952
pubmed: 28333925
Eye (Lond). 2020 Sep;34(9):1563-1569
pubmed: 32152516
Eur Respir J. 1999 Nov;14(5):1034-7
pubmed: 10596686
Patient Educ Couns. 2008 Jul;72(1):26-33
pubmed: 18314294
Dermatol Online J. 2017 Sep 15;23(9):
pubmed: 29469713
J Gen Intern Med. 2012 Oct;27(10):1317-25
pubmed: 22592354
Int J Chron Obstruct Pulmon Dis. 2018 Sep 05;13:2759-2766
pubmed: 30233166
Respir Med. 2011 Jun;105(6):907-15
pubmed: 21295958
NPJ Prim Care Respir Med. 2017 Dec;27(1):9
pubmed: 28184045
J Gen Intern Med. 2011 Jun;26(6):635-42
pubmed: 21249463
Pulm Pharmacol Ther. 2017 Oct;46:16-19
pubmed: 28797611
PLoS One. 2018 Oct 16;13(10):e0201188
pubmed: 30325931
Ann Pharmacother. 1993 Jul-Aug;27(7-8):922-7
pubmed: 8364279
Respir Med. 2011 Jun;105(6):930-8
pubmed: 21367593
J Asthma. 2018 Jul;55(7):801-810
pubmed: 28800268
Respir Care. 2005 Oct;50(10):1360-74; discussion 1374-5
pubmed: 16185371
J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):823-32
pubmed: 27587316
Int J Chron Obstruct Pulmon Dis. 2015 Jul 08;10:1291-8
pubmed: 26185435
Saudi Med J. 2011 Oct;32(10):1028-33
pubmed: 22008922
Respir Res. 2018 Jan 16;19(1):10
pubmed: 29338792
Allergy Asthma Proc. 2009 Mar-Apr;30(2):181-5
pubmed: 19463207
J Asthma. 2011 Aug;48(6):616-24
pubmed: 21623690
Cochrane Database Syst Rev. 2017 Mar 13;3:CD012286
pubmed: 28288272
J Family Med Prim Care. 2019 Jan;8(1):246-250
pubmed: 30911514
Eur Respir J. 1999 Jul;14(1):32-8
pubmed: 10489826
Respir Med. 2018 Oct;143:103-108
pubmed: 30261980
Ther Adv Respir Dis. 2007 Dec;1(2):85-92
pubmed: 19124350
Arq Bras Cardiol. 2014 Dec;103(6):503-12
pubmed: 25590930
Ann Am Thorac Soc. 2016 Jun;13(6):816-24
pubmed: 26998961
J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):802-12
pubmed: 27587314
Respiration. 2014;88(1):3-15
pubmed: 24902629
J Bras Pneumol. 2015 Nov-Dec;41(6):496-501
pubmed: 26785957
J Card Fail. 2011 Oct;17(10):789-96
pubmed: 21962415
Int J Chron Obstruct Pulmon Dis. 2014 Jul 17;9:753-8
pubmed: 25092972
Patient Prefer Adherence. 2019 Jul 31;13:1325-1334
pubmed: 31534319
J Asthma. 2010 Apr;47(3):251-6
pubmed: 20394511
Saudi Pharm J. 2018 Dec;26(8):1127-1136
pubmed: 30532633
Respir Med. 2005 Dec;99 Suppl B:S11-8
pubmed: 16236492
Int J Chron Obstruct Pulmon Dis. 2021 Mar 10;16:603-613
pubmed: 33731990
Med Care. 1986 Jan;24(1):67-74
pubmed: 3945130
COPD. 2020 Apr;17(2):197-204
pubmed: 32237908
J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1032-1039.e1
pubmed: 28065689
J Asthma. 2010 Mar;47(2):202-8
pubmed: 20170330
PLoS One. 2022 Oct 7;17(10):e0275778
pubmed: 36206237
Ann Thorac Med. 2008 Apr;3(2):44-7
pubmed: 19561904
J Asthma. 2014 May;51(4):440-5
pubmed: 24393080